HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Meilan Zhang Selected Research

Drug Therapy (Chemotherapy)

12/2021circRNA-miRNA-mRNA in breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Meilan Zhang Research Topics

Disease

6Neoplasms (Cancer)
06/2022 - 11/2016
3Neoplasm Metastasis (Metastasis)
06/2022 - 12/2021
3Autoimmune Diseases (Autoimmune Disease)
03/2009 - 05/2007
2Fibrosis (Cirrhosis)
10/2021 - 02/2021
2Pulmonary Fibrosis (Fibrosing Alveolitis)
10/2021 - 02/2021
2B-Cell Lymphoma (Lymphoma, B Cell)
01/2021 - 05/2008
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2021 - 02/2018
2Philadelphia Chromosome
01/2021 - 02/2018
2Liver Neoplasms (Liver Cancer)
01/2020 - 11/2016
2Prion Diseases (Transmissible Spongiform Encephalopathies)
12/2019 - 01/2018
1Neuroblastoma
05/2022
1Cytokine Release Syndrome
01/2022
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2022
1Breast Neoplasms (Breast Cancer)
12/2021
1Asthma (Bronchial Asthma)
10/2021
1Chronic Obstructive Pulmonary Disease (COPD)
01/2021
1Hypoxia (Hypoxemia)
01/2020
1Scrapie
12/2019
1Hepatocellular Carcinoma (Hepatoma)
03/2018
1Infections
01/2015
1Medically Unexplained Symptoms
03/2012
1Psoriasis (Pustulosis Palmaris et Plantaris)
03/2009
1Skin Diseases (Skin Disease)
03/2009
1Burkitt Lymphoma (Burkitt's Lymphoma)
05/2008
1Lymphoma (Lymphomas)
05/2007

Drug/Important Bio-Agent (IBA)

3Circular RNAIBA
06/2022 - 12/2021
3Biological ProductsIBA
06/2022 - 12/2021
3Biomarkers (Surrogate Marker)IBA
12/2021 - 01/2021
2Chimeric Antigen ReceptorsIBA
01/2022 - 01/2021
2Proteins (Proteins, Gene)FDA Link
10/2021 - 01/2020
2Long Noncoding RNAIBA
02/2021 - 01/2021
2Prion ProteinsIBA
12/2019 - 01/2018
2Monoclonal AntibodiesIBA
05/2008 - 05/2007
1RNA (Ribonucleic Acid)IBA
05/2022
1LuciferasesIBA
05/2022
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
01/2022
1Messenger RNA (mRNA)IBA
12/2021
1MicroRNAs (MicroRNA)IBA
12/2021
1Transforming Growth Factor-beta Type II ReceptorIBA
10/2021
1OvalbuminIBA
10/2021
1atractylonIBA
10/2021
1Bleomycin (Blenoxane)FDA LinkGeneric
02/2021
1indium-bleomycinIBA
02/2021
1Transforming Growth Factors (Transforming Growth Factor)IBA
02/2021
1AntigensIBA
01/2021
1Diethylnitrosamine (N-Nitrosodiethylamine)IBA
01/2020
1EnzymesIBA
01/2020
1Glucose (Dextrose)FDA LinkGeneric
01/2020
1Adenosine Triphosphate (ATP)IBA
01/2020
1Transcription Factors (Transcription Factor)IBA
01/2020
1ginsenoside M1IBA
01/2020
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
02/2018
1STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
11/2016
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2016
1Anti-Bacterial Agents (Antibiotics)IBA
01/2015
14-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA
03/2012
1Lymphocyte Function-Associated Antigen-1 (LFA-1)IBA
03/2009
1AntibodiesIBA
03/2009
1LigandsIBA
03/2009
1efalizumab (Raptiva)FDA Link
03/2009
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
03/2009
1Immunoglobulin Fab FragmentsIBA
05/2008
1Complement System Proteins (Complement)IBA
05/2008
1Peptides (Polypeptides)IBA
05/2008
1EpitopesIBA
05/2008
1Rituximab (Mabthera)FDA Link
05/2007
1Pharmaceutical PreparationsIBA
05/2007

Therapy/Procedure

5Therapeutics
01/2021 - 11/2016
3Immunotherapy
01/2022 - 01/2021
1Drug Therapy (Chemotherapy)
12/2021